Real-time enrollment status for this neuroendocrine tumors clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:27 PM UTC
| NCT Number | NCT06943755 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Tumors |
| Phase | PHASE2 |
| Target Enrollment | 440 participants |
| Active Locations | 40 sites in the US |
| Sponsor | Exelixis |
| Last Updated on CT.gov | July 9, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06943755 is currently recruiting participants. This phase2 study for neuroendocrine tumors is actively seeking new participants at 40 locations across the United States. The study is sponsored by Exelixis. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06943755 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06943755 was last updated 1 week ago (July 9, 2026). HelloStudys verifies this status automatically.